# FDA WARNING_LETTER - ATLRx, Inc. - May 04, 2022

Source: https://www.globalkeysolutions.net/records/warning_letter/atlrx-inc/422ab777-fee9-4b5e-afd9-2f5bc8a0057c

> FDA WARNING_LETTER for ATLRx, Inc. on May 04, 2022. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: WARNING_LETTER
- Company Name: ATLRx, Inc.
- Inspection Date: 2022-05-04
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Officers

- [Director](https://www.globalkeysolutions.net/people/ann-m-oxenham/0013a6c1-4908-4506-9fb8-d0aa522e4ad4)
- [Director](https://www.globalkeysolutions.net/people/donald-d-ashley/060f0dda-e6e8-4f9c-97e7-f540d523d902)
- [Division Director](https://www.globalkeysolutions.net/people/neal-bataller/801e1974-b20c-4b7a-ace7-aa4554fce4b6)

Company: https://www.globalkeysolutions.net/companies/atlrx-inc/cae56d84-c382-4412-aa4f-594a92c2cdaa

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c